Joint position statement of the International Federation of Sports Medicine (FIMS) and European Federation of Sports Medicine Associations (EFSMA) on the IOC framework on fairness, inclusion and non-discrimination based on gender identity and sex variations.
[en] The IOC recently published its framework on fairness, inclusion and non-discrimination based on gender identity and sex variations. This framework is drafted mainly from a human rights perspective, with less consideration for medical/scientific issues. The framework places the onus for gender eligibility and classification entirely on the International Federations (IFs), even though most will not have the capacity to implement the framework. The position of no presumption of advantage is contrary to the 2015 IOC consensus. Implementation of the 2021 framework will be a major challenge for IFs that have already recognised the inclusion of trans and women athletes with differences of sexual development (DSD) using a scientific/medical solution. The potential consequences for sports that need to prioritise fairness or safety could be one of two extremes (1) exclusion of all transgender or DSD athletes on the grounds of advantage or (2) self-identification that essentially equates to no eligibility rules. Exclusion of all transgender or DSD athletes is contrary to the Olympic charter and unlawful in many countries. While having no gender eligibility rules, sport loses its meaning and near-universal support. Athletes should not be under pressure to undergo medical procedures or treatment to meet eligibility criteria. However, if an athlete is fully informed and consents, then it is their free choice to undergo carefully considered or necessary interventions for gender classification for sport to compete fairly and safely in their chosen gender. Free choice is a fundamental human right, but so is the right to fair and safe competition.
Disciplines :
Orthopedics, rehabilitation & sports medicine
Author, co-author :
Pigozzi, Fabio
Bigard, Xavier
Steinacker, Juergen
Wolfarth, Bernd
Badtieva, Victoriya
Schneider, Christian
Swart, Jeroen
Bilzon, James Lee John
Constantinou, Demitri
Dohi, Michiko
Di Luigi, Luigi
Fossati, Chiara
Bachl, Norbert
Li, Guoping
Papadopoulou, Theodora
Casasco, Maurizio
Janse van Rensburg, Dina Christina Christa
Kaux, Jean-François ; Université de Liège - ULiège > Département des sciences de la motricité > Médecine physique, réadaptation et traumatologie du sport
Joint position statement of the International Federation of Sports Medicine (FIMS) and European Federation of Sports Medicine Associations (EFSMA) on the IOC framework on fairness, inclusion and non-discrimination based on gender identity and sex variations.
International Olympic Committee. Framework on fairness, inclusion and non-discrimination on the basis of gender identity and sex variations, 2021. Available: https://stillmed.olympics.com/media/ Documents/News/2021/11/IOC-Framework-Fairness-Inclusion-Nondiscrimination-2021.pdf
International Olympic Committee. Consensus meeting on sex reassignment and hyperandrogenism November 2015, 2015. Available: https://stillmed.olympic.org/Documents/Commissions PDFfiles/Medicalcommission/2015-11iocconsensusmeeting onsexreassignmentandhyperandrogenism-en.pdf
Handelsman DJ, Hirschberg AL, Bermon S. Circulating testosterone as the hormonal basis of sex differences in athletic performance. Endocr Rev 2018;39:803-29.
Handelsman DJ, Bermon S. Detection of testosterone doping in female athletes. Drug Test Anal 2019;11:1566-71.
Hamilton BR, Lima G, Barrett J. Integrating Transwomen and female athletes with differences of sex development (DSD) into elite competition: the FIMS 2021 consensus statement. Sports Med 2021;51.
World Athletics. Eligibility regulations for the female classification (athletes with differences of sex development), 2019. Available: https://www.worldathletics.org/about-iaaf/documents/book-of-rules
World Athletics. Eligibility regulations transgender athletes, 2019. Available: https://www.worldathletics.org/about-iaaf/documents/ book-of-rules
World Rugby. World rugby transgender guideline, 2020. Available: https://playerwelfare.worldrugby.org/?documentid=231
USA Gymnastics. USA gymnastic policy for transgender inclusion, 2020. Available: https://usagym.org/PDFs/About%20USA% 20Gymnastics/transgenderpolicy.pdf
International Tennis Federation. Transgender policy, 2018. Available: https://www.itftennis.com/media/2163/itf-transgender-policy.pdf
Scottish Womens Football Association. Transgender and transsexual policy, 2019. Available: https://scotwomensfootball.com/wp-content/ uploads/2019/03/SWF-Policy-Transgender-People-Playing-in-SWFFINAL. pdf
Steinacker JM, Koubaa D, Nielsen HB, et al. Statement of FISA sports medicine Commission: biological effects of testosterone. Dtsch Z Sportmed 2019;2019:83-4.
Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev 1987;8:1-28.
Institute of Medicine, Board on Health Sciences Policy, Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy. Testosterone and aging: clinical research directions. National Academies Press, 2004.
Nickerson BS, McLester CN, McLester JR, et al. Relative accuracy of anthropometric-based body fat equations in males and females with varying BMI classifications. Clin Nutr ESPEN 2020;35:136-40.
World Anti-Doping Agency. What is prohibited: anabolic agents, 2021. Available: https://www.wada-ama.org/en/content/what-isprohibited/ prohibited-at-all-times/anabolic-agents
Hamilton BR, Martinez-Patino MJ, Barrett J, et al. Response to the United nations human rights Council's report on race and gender discrimination in sport: an expression of concern and a call to Prioritise research. Sports Med 2021;51:839-42.
Hamilton BR, Guppy FM, Barrett J, et al. Integrating transwomen athletes into elite competition: the case of elite archery and shooting. Eur J Sport Sci 2021;21:1500-9.
Gorin-Lazard A, Baumstarck K, Boyer L, et al. Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. J Sex Med 2012;9:531-41.
Wierckx K, Mueller S, Weyers S, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med 2012;9:2641-51.
Unger CA. Hormone therapy for transgender patients. Transl Androl Urol 2016;5:877-84.
Coleman E. Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People: An Introduction. In: Principles of gender-specific medicine. Elsevier, 2017: 69-75.
Safer JD, Tangpricha V. Care of transgender persons. N Engl J Med Overseas Ed 2019;381:2451-60.
Klein DA, Paradise SL, Reeder RM. Amenorrhea: a systematic approach to diagnosis and management. Am Fam Physician 2019;100:39-48.
World Rowing Federation. Rule 15 and Bye law to rule 15-Men's and Women's Events, 2020. Available: www.worldrowing.com
Union Cycliste Internationale. Part 13 medical rules: chapter V eligibility regulations for transgender athletes, 2020. Available: https://archive.uci.org/docs/default-source/rules-and-regulations/ part-xiii-medical-rules-01.03.2020.pdf
International Olympic Committee. Olympic charter, 2020. Available: www.olympic.org\\documents\\olympic-charter
USA Hockey. Transgender athlete eligibility policy, 2019. Available: https://cdn3.sportngin.com/attachments/document/8a0b-1766565/ USAHockeyTransgenderAthleteEligibilityPolicy.pdf